Xeris Biopharma Holdings, Inc. XERS Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $111.75M+0.6% | $111.04M+21.2% | $91.6M+54.5% | $59.29M+1.4% | $58.44M-18.4% | ||
| $56.3M+10.3% | $51.05M-5.0% | $53.75M+1.3% | $53.05M+14.5% | $46.33M+14.6% | ||
| $74.23M+8.1% | $68.67M+1.8% | $67.46M+0.3% | $67.28M+27.7% | $52.69M+9.4% | ||
| $251.68M+4.7% | $240.31M+7.3% | $224.02M+20.7% | $185.58M+13.5% | $163.49M-2.5% | ||
| $5.03M+1.8% | $4.95M0.0% | $4.95M-6.4% | $5.28M+0.5% | $5.26M-5.4% | ||
| $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | ||
| $85.37M-3.1% | $88.08M-3.0% | $90.79M-2.9% | $93.5M-2.8% | $96.21M-2.7% | ||
| $392.01M+2.2% | $383.53M+3.6% | $370.19M+10.6% | $334.69M+6.1% | $315.45M-2.4% | ||
| $11.47M+273% | $3.08M-52.9% | $6.53M-31.0% | $9.46M+49.0% | $6.35M+177% | ||
| $118.59M+8.2% | $109.57M-5.7% | $116.2M+22.1% | $95.17M+0.1% | $95.07M-5.3% | ||
| $221.22M+0.4% | $220.34M+0.4% | $219.47M+0.4% | $218.63M+0.4% | $217.81M+0.4% | ||
| $379M+2.5% | $369.84M-0.3% | $371.05M+4.8% | $353.99M+1.0% | $350.58M-0.6% | ||
| $18K+5.9% | $17K0.0% | $17K+6.3% | $16K0.0% | $16K+6.7% | ||
| -$669.07M+0.3% | -$671.31M+1.6% | -$682.39M+0.1% | -$683.01M-0.3% | -$681.08M-1.4% | ||
| $13.01M-5.0% | $13.69M+1,690% | -$861K+95.5% | -$19.3M+45.0% | -$35.13M-18.6% | ||
| $392.01M+2.2% | $383.53M+3.6% | $370.19M+10.6% | $334.69M+6.1% | $315.45M-2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Xeris Biopharma Holdings, Inc.'s total assets?
- Xeris Biopharma Holdings, Inc. (XERS) holds $392.0M in total assets, up 24.3% year over year.
- How much debt does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. carries $258.6M in total debt against $13.0M of shareholders' equity, a debt-to-equity ratio of 19.87.
- How much cash does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. holds $111.8M in cash and equivalents.
- Can Xeris Biopharma Holdings, Inc. cover its short-term obligations?
- Its current ratio is 2.12 — current assets exceed current liabilities.
- Where does Xeris Biopharma Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
